TFFP News and Press, TFF Pharmaceuticals Inc - Ordinary Shares From 06/01/22

FORT WORTH, Texas, June 01, 2022 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announc...

TFFP is a platform company with leading technology. Clinical/FDA risk is extremely low. The stock is drastically undervalued based on only fraction of the pipeline and multiples of upside. Multiple insider purchases support the bull case and timing. For further details s...

FORT WORTH, Texas, May 20, 2022 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announce...

Image source: The Motley Fool. TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) Q1 2022 Earnings Call May 11, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: TFF Pharmaceuticals, Inc. (TFFP) Q1 2022 Earnings Call Transcript...

TFF Pharmaceuticals, Inc. (TFFP) Q1 2022 Earnings Conference Call May 11, 2022, 16:30 ET Company Participants Corey Davis - LifeSci Advisors Glenn Mattes - President, CEO & Director Kirk Coleman - CFO, Treasurer & Secretary Christopher Cano - COO & VP, Business Development Bill Wi...

Announced Collaboration with Catalent to Further Expand Thin Film Freezing Applications with a Focus on Biologic Drug Development Announced Second CRADA Agreement with USAMRIID and Geneva Foundation to Develop Novel Therapies Using Thin Film Freez...

ACOR, ADMA, APP, ASM, ASND, ASYS, ATCO, BAK, BMBL, BROS, BYND, CLPT, CLSD, CPA, CPNG, CYCC, DIS, DOX, ENVX, FLNC, FOSL, FSM, GAIN, GBDC, ICAD, KGC, LGO, LKCO, LTBR, MBII, METC, MFC, MQ, MRAM, MYO, NEON, NOAH, OCX, ONTX, OR, OTRK, PAAS, PAYS, PSTL, OTCPK:PWCDF, RIVN, SAND, SCM, SCTL, SLF, SMTS...

Thin Film Freezing Technology Co-Inventor Dr. Robert O. Williams III to Deliver Platform Presentation of Data on Stabilizing and Delivering Antivirals, Antibodies and Vaccines using Thin Film Freezing Technology in the Fight Against COVID-19 Members of Dr. Williams’ Lab a...

FORT WORTH, Texas, April 29, 2022 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announ...

The clinical-stage company TFF Pharmaceuticals (NASDAQ:TFFP) announced safety and pharmacokinetic (PK) results from its Phase 1 study of Niclosamide Inhalation Powder in COVID-19 on Tuesday. The company plans to use its Thin Film Freezing (TFF) technology to target the affected lungs with an ...